The initial success of Viagra undeniably reshaped the pharmaceutical landscape, but investing in companies heavily reliant on generic versions presents a challenging picture. Although early profits were significant, the end of patents and the emergence of cheaper alternatives have weakened the customer base. Thus, a thorough assessment of current r